• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4662778)   Today's Articles (12900)   Subscriber (51569)
Download
Number Citation Analysis
1
Muir JM, Radhakrishnan A, Ozer Stillman I, Sarri G. Health Equity Considerations in Cost-Effectiveness Analysis: Insights from an Umbrella Review. CLINICOECONOMICS AND OUTCOMES RESEARCH 2024;16:581-596. [PMID: 39184340 PMCID: PMC11344546 DOI: 10.2147/ceor.s471827] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2024] [Accepted: 07/16/2024] [Indexed: 08/27/2024]  Open
2
Muir JM, Radhakrishnan A, Freitag A, Ozer Stillman I, Sarri G. Reconstructing the value puzzle in health technology assessment: a pragmatic review to determine which modelling methods can account for additional value elements. Front Pharmacol 2023;14:1197259. [PMID: 37521458 PMCID: PMC10372435 DOI: 10.3389/fphar.2023.1197259] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2023] [Accepted: 07/05/2023] [Indexed: 08/01/2023]  Open
3
Su W, Quon P, Whalen J, Ranganathan G, Wronski S, Mwamburi M, Knopf KB, Sterchele JA, Salvador CG, Ozer Stillman I, Kadambi A. Cost-effectiveness analysis of bendamustine plus rituximab versus CHOP-R in treatment-naive patients with mantle cell (MCL) and indolent lymphomas (IL). J Clin Oncol 2012. [DOI: 10.1200/jco.2012.30.15_suppl.6553] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
ESCI (1)